Qitan Technology

company

About

Qitan Technology is a Developer of a genome sequencing technology.

  • 51 - 100

Details

Last Funding Type
Series C
Last Funding Money Raised
¥700M
Industries
Biotechnology,Health Care
Founded date
Jan 1, 2016
Number Of Employee
51 - 100
Operating Status
Active

Developer of a genome sequencing technology. The company takes advantage of nanopores to sequence single nucleic acid molecules.Using innovative nanopore gene sequencing technology, it provides single-molecule sequencing capability with long reading length, real-time output of sequencing results, low single-running cost, small and convenient instrument, and cost-effective gene sequencing solution without complicated library preparation. It can directly detect the apparent modification of nucleic acids and expand the application of gene sequencing technology in cutting-edge biological research and clinical medicine such as instant diagnosis, metagenomics, epigenetics, RNA and transcriptomics.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
5
¥1.24B
Qitan Technology has raised a total of ¥1.24B in funding over 2 rounds. Their latest funding was raised on Dec 23, 2022 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 23, 2022 Series C ¥700M 1 Meituan Detail
Jun 8, 2021 Series B ¥400M 1 Detail
May 13, 2020 Series A ¥100M 1 Detail
Aug 8, 2019 Series Unknown ¥40M 1 Yahui Precision Medicine Fund Detail
Apr 1, 2017 Series A ¥3M 1 Detail

Investments

Number of Investments
Number of Lead Investments
3
1
Qitan Technology has made 3 investments. Their most recent investment was on Mar 1, 2022, when CyberBox raised $150K.
Date Company Name
Round Money Raised Industry Lead Investor
Mar 1, 2022 CyberBox
Seed $150K Cryptocurrency Yes
Dec 1, 2021 Coinprofile
Pre-seed $600K Blockchain
Dec 1, 2021 Payourse
Pre-seed $600K Blockchain

Investors

Number of Lead Investors
Number of Investors
2
4
Qitan Technology is funded by 4 investors. Meituan and Gaorong Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Meituan Yes Series C
Gaorong Capital Series B
Yahui Precision Medicine Fund Series A
Tsinghua Technology Transfer Fund Series A